Consumer

Following a soft launch last year, the chemoWave disease companion app has now been fully released for chemotherapy patients interested in better managing their care, symptoms, and side effects.

A new alcohol and drug recovery app that incentives users with its own cryptocurrency hit the market this week.

Mirror, a New York City-based virtual fitness platform company, has raised $13 million in a new funding round led by Spark Capital.

With influenza running rampant and several other infections waiting in the wings, some may be interested in knowing whether a specific disease is common in their community.

Whether you're Tom Brady or Nick Foles, getting a good night's sleep is key for professional athletes.

San Francisco- and Zurich-based Ava, which makes a bracelet capable of tracking women’s menstrual cycles, has announced an update that will better allow their device to track when, or even if, the wearer has ovulated, according to a statement from the company.

Consumers now have another option to turn to when looking for a  new doctor with the recent launch of mobile provider search tool Welloh.

When Fitbit acquired indie smartwatch maker Pebble at the end of 2016, it was clear from the beginning that it would be the end of the line for Pebble devices.

New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.

Nokia has announced that it will disable the pulse wave velocity measurement feature on its Withings’ Body Cardio scale as of January 24.